医药包装市场机会、成长动力、产业趋势分析及2025-2034年预测

2024 年全球医药包装市场价值为 1,515 亿美元，预计 2025 年至 2034 年期间的复合年增长率为 15.6%。对生物製药的需求不断增长以及对防篡改和儿童安全包装的日益重视是推动成长的关键因素。生物製剂的进步和个人化医疗的激增加速了对确保稳定性和功效的专门包装解决方案的需求。因此，各公司正加强研发力度，推出符合严格监管要求的创新材料和形式。

製药业越来越依赖先进的包装来保存复杂的生物製剂，这为製造商带来了新的机会。低温和温度敏感包装解决方案越来越受到关注，以满足生物製药的储存和运输需求。此外，对病人安全的高度关注和严格的法规正在促使公司投资于防止意外摄入的保护性包装概念。製药公司正在采用 RFID 追踪和温度指示器等智慧功能来提高药物的可追溯性和依从性。

市场分为初级包装、二级包装和三级包装。预计到 2034 年，初级包装的市场规模将超过 4,312 亿美元。随着製造商优先考虑药品安全和合规性，对智慧和互动式包装（包括儿童安全、防篡改解决方案）的需求正在增加。生物製剂和个人化医疗的扩展进一步推动了对维持产品完整性的高阻隔材料的需求。

根据材料，市场分为塑胶和聚合物、纸和纸板、玻璃和金属。 2024 年，塑胶和聚合物占据了总市场份额的 43.4%，因其多功能性、重量轻和耐用性而成为首选。永续性议题推动了生物基、可回收和可生物降解塑胶的采用，以减少对环境的影响并满足不断变化的监管标准。

市场也按产品类型细分，包括瓶子、注射器、泡罩包装、小瓶和安瓿瓶、小袋、小袋和药管。瓶子是该领域的佼佼者，2024 年市场规模达 453 亿美元。由于瓶子方便易用，製药业继续青睐用于固体和液体药物包装的瓶子。向永续替代品（包括可回收和生物基塑胶瓶）的转变反映了人们为减少生态足迹所做的持续努力。

根据应用，市场包括口服药物、注射药物、外用药物、鼻腔药物和静脉注射药物。 2024 年口服药物包装规模将达到 525 亿美元，其中泡罩包装、瓶子和小袋仍然是最常用的形式。增强型儿童安全设计和内建剂量追踪指示器越来越受欢迎，有助于确保用药依从性和安全性。

2024 年，北美以 34.8% 的市占率领先全球医药包装市场。仅美国就贡献了 461 亿美元，这得益于严格的监管框架以及对药品生产和医疗保健进步的大量投资。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 新型药品包装系统不断创新
    • 生物製药需求不断成长
    • 慢性病盛行率不断上升
    • 越来越多地使用先进的药物传输系统
    • 包装中对儿童安全、防篡改功能的需求不断增长
  • 产业陷阱与挑战
    • 假药和假包装
    • 获得优质医疗服务的机会有限或不足
• 成长潜力分析
• 监管格局
• 技术格局
• 未来市场趋势
• 差距分析
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：依产品类型，2021 年至 2034 年

• 主要趋势
• 泡罩包装
• 瓶子
• 注射器
• 小瓶和安瓿瓶
• 小袋
• 袋装
• 药管
• 其他的

第六章：市场估计与预测：按材料，2021 年至 2034 年

• 主要趋势
• 塑胶
  • 聚乙烯（PE）
  • 聚对苯二甲酸乙二醇酯（PET）
  • 聚丙烯（PP）
  • 聚苯乙烯（PS）
  • 聚氯乙烯（PVC）
  • 其他的
• 纸和纸板
• 玻璃
• 金属

第七章：市场估计与预测：依包装类型，2021 年至 2034 年

• 主要趋势
• 初级包装
• 二次包装
• 三级包装

第 8 章：市场估计与预测：按应用，2021 年至 2034 年

• 主要趋势
• 口服药物
• 注射药物
• 外用药物
• 鼻腔药物
• 静脉注射（IV）药物
• 其他的

第九章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋

第十章：公司简介

• Adelphi
• Amcor
• Aptar CSP Technologies
• Berry Global
• Catalent
• CCL Industries
• Comar
• Constantia Flexibles
• Drug Plastics & Glass
• DS Smith
• Eastman Chemical
• Gerresheimer
• Huhtamaki
• Mayr-Melnhof Karton
• Nipro
• Origin Pharma Packaging
• ProAmpac
• Schott Pharma
• SGD Pharma
• Silgan
• Sonoco
• West Pharmaceutical
• WestRock

The Global Pharmaceutical Packaging Market was valued at USD 151.5 billion in 2024 and is anticipated to expand at a CAGR of 15.6% from 2025 to 2034. The rising demand for biopharmaceuticals and the increasing emphasis on tamper-evident and child-resistant packaging are key factors driving growth. Advances in biologics and the surge in personalized medicine are accelerating the need for specialized packaging solutions that ensure stability and efficacy. As a result, companies are ramping up research and development efforts to introduce innovative materials and formats that align with stringent regulatory requirements.

The pharmaceutical industry's growing reliance on advanced packaging to preserve complex biological formulations presents new opportunities for manufacturers. Cryogenic and temperature-sensitive packaging solutions are gaining traction to address the storage and transportation needs of biopharmaceuticals. Additionally, the heightened focus on patient safety and stringent regulations are pushing companies to invest in protective packaging concepts that prevent accidental ingestion. Pharmaceutical firms are incorporating smart features such as RFID-enabled tracking and temperature indicators to improve drug traceability and adherence.

The market is categorized into primary, secondary, and tertiary packaging. Primary packaging is projected to surpass USD 431.2 billion by 2034. The demand for smart and interactive packaging, including child-resistant and tamper-proof solutions, is increasing as manufacturers prioritize drug safety and compliance. The expansion of biologics and personalized medicine is further fueling the need for high-barrier materials that maintain product integrity.

Based on material, the market is divided into plastics and polymers, paper and paperboard, glass, and metal. Plastics and polymers accounted for 43.4% of the total market share in 2024, serving as the preferred choice due to their versatility, lightweight nature, and durability. Sustainability concerns are driving the adoption of bio-based, recyclable, and biodegradable plastics to reduce environmental impact and meet evolving regulatory standards.

The market is also segmented by product type, including bottles, syringes, blister packs, vials and ampoules, sachets, pouches, and medication tubes. Bottles led the segment, generating USD 45.3 billion in 2024. The pharmaceutical industry continues to favor bottles for solid and liquid drug packaging due to their convenience and ease of use. The shift toward sustainable alternatives, including recycled and bio-based plastic bottles, reflects growing efforts to minimize ecological footprint.

By application, the market includes oral drugs, injectable drugs, topical drugs, nasal drugs, and intravenous drugs. Oral drug packaging reached USD 52.5 billion in 2024, with blisters, bottles, and sachets remaining the most utilized formats. Enhanced child-resistant designs and built-in indicators to track dosages are gaining popularity, supporting medication adherence and safety.

North America led the global pharmaceutical packaging market with a 34.8% share in 2024. The United States alone contributed USD 46.1 billion, driven by strict regulatory frameworks and substantial investments in medicine production and healthcare advancements.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing innovation in novel drug packaging systems
    • 3.2.1.2 Rising demand for biopharmaceuticals
    • 3.2.1.3 Increasing prevalence of chronic diseases
    • 3.2.1.4 Increasing use of advanced drug delivery systems
    • 3.2.1.5 Rising demand for child-resistant and tamper-evident features in packaging
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Counterfeit drugs and fake packaging
    • 3.2.2.2 Limited or Inadequate access to quality medical care
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 (USD Bn & Kilo Tons)

• 5.1 Key trends
• 5.2 Blister packs
• 5.3 Bottles
• 5.4 Syringes
• 5.5 Vials & ampoules
• 5.6 Sachets
• 5.7 Pouches
• 5.8 Medication tubes
• 5.9 Others

Chapter 6 Market Estimates and Forecast, By Material, 2021 – 2034 (USD Bn & Kilo Tons)

• 6.1 Key trends
• 6.2 Plastics
  • 6.2.1 Polyethylene (PE)
  • 6.2.2 Polyethylene terephthalate (PET)
  • 6.2.3 Polypropylene (PP)
  • 6.2.4 Polystyrene (PS)
  • 6.2.5 Polyvinyl chloride (PVC)
  • 6.2.6 Others
• 6.3 Paper & paperboard
• 6.4 Glass
• 6.5 Metal

Chapter 7 Market Estimates and Forecast, By Packaging Type, 2021 – 2034 (USD Bn & Kilo Tons)

• 7.1 Key trends
• 7.2 Primary packaging
• 7.3 Secondary packaging
• 7.4 Tertiary packaging

Chapter 8 Market Estimates and Forecast, By Application, 2021 – 2034 (USD Bn & Kilo Tons)

• 8.1 Key trends
• 8.2 Oral drugs
• 8.3 Injectable drugs
• 8.4 Topical drugs
• 8.5 Nasal drugs
• 8.6 Intravenous (IV) drugs
• 8.7 Others

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 (USD Bn & Kilo Tons)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Adelphi
• 10.2 Amcor
• 10.3 Aptar CSP Technologies
• 10.4 Berry Global
• 10.5 Catalent
• 10.6 CCL Industries
• 10.7 Comar
• 10.8 Constantia Flexibles
• 10.9 Drug Plastics & Glass
• 10.10 DS Smith
• 10.11 Eastman Chemical
• 10.12 Gerresheimer
• 10.13 Huhtamaki
• 10.14 Mayr-Melnhof Karton
• 10.15 Nipro
• 10.16 Origin Pharma Packaging
• 10.17 ProAmpac
• 10.18 Schott Pharma
• 10.19 SGD Pharma
• 10.20 Silgan
• 10.21 Sonoco
• 10.22 West Pharmaceutical
• 10.23 WestRock